Pharmaceutical Executive June 9, 2023
Sharlene Jenner

The new era of generative AI is poised to impact pharma marketing and engagement in powerful and lasting ways. But amid all the technological praise, what are the key considerations brand teams must navigate?

Ask any pharmaceutical marketer or strategist about ChatGPT or any of the more than 2,000 new artificial intelligence (AI) platforms introduced in the last three months, and you’ll get answers that range from, “This is the most amazing thing” to “I’m not sure how to use it effectively.” No matter how you feel about this shift in technology, it’s here, and it’s disrupting everything we know about marketing and engagement.

For the digital natives, there is wild optimism about where AI and machine learning can take...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Biotechnology, Pharma, Pharma / Biotech, Technology
How healthcare's view of AI has shifted
The Power of Drug Discovery with Philip Tagari
Bite-Sized AI: Why Smaller Models Like Microsoft’s Phi-3 Are Big for Business
Coventry Uni uses AI-generated avatars to train medical students
Lessons on generative AI in medicine from Stanford University

Share This Article